MX9205077A - Preparado farmaceutico estable y procedimiento para su fabricacion. - Google Patents
Preparado farmaceutico estable y procedimiento para su fabricacion.Info
- Publication number
- MX9205077A MX9205077A MX9205077A MX9205077A MX9205077A MX 9205077 A MX9205077 A MX 9205077A MX 9205077 A MX9205077 A MX 9205077A MX 9205077 A MX9205077 A MX 9205077A MX 9205077 A MX9205077 A MX 9205077A
- Authority
- MX
- Mexico
- Prior art keywords
- procedure
- manufacture
- pharmaceutical preparation
- stable pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4130173A DE4130173A1 (de) | 1991-09-11 | 1991-09-11 | Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9205077A true MX9205077A (es) | 1993-03-01 |
Family
ID=6440342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9205077A MX9205077A (es) | 1991-09-11 | 1992-09-04 | Preparado farmaceutico estable y procedimiento para su fabricacion. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5599824A (es) |
EP (1) | EP0531845B1 (es) |
JP (1) | JPH05229945A (es) |
AT (1) | ATE141052T1 (es) |
CA (1) | CA2077704C (es) |
DE (2) | DE4130173A1 (es) |
DK (1) | DK0531845T3 (es) |
ES (1) | ES2090432T3 (es) |
GR (1) | GR3020962T3 (es) |
HK (1) | HK41697A (es) |
MX (1) | MX9205077A (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287693B1 (en) | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
ES2537563T3 (es) | 2003-06-13 | 2015-06-09 | Skendi Finance, Ltd. | Formulación de estradiol-progesterona de liberación lenta |
CN1824647B (zh) * | 2005-02-22 | 2011-04-20 | 田边三菱制药株式会社 | (±)2-(二甲基氨基)-1-{[O-(m-甲氧基苯乙基)苯氧基]甲基}乙基氢琥珀酸酯盐酸盐的晶体 |
US9399019B2 (en) | 2012-05-09 | 2016-07-26 | Evonik Corporation | Polymorph compositions, methods of making, and uses thereof |
WO2018039039A1 (en) * | 2016-08-23 | 2018-03-01 | Edge Therapeutics, Inc. | Scalable microparticulate formulations containing polymorphic nimodipine form 2 prepared by a solvent evaporation process |
WO2019018306A1 (en) * | 2017-07-17 | 2019-01-24 | Edge Therapeutics, Inc. | ADVANCED MICROPARTICULAR FORMULATIONS CONTAINING FORM 2 OF MICRONIZED POLYMORPHIC NIMODIPINE |
USD867911S1 (en) * | 2018-10-10 | 2019-11-26 | Adel J M S Alabdin | Combination gas leak sensor and communication device |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932645A (en) * | 1971-04-10 | 1976-01-13 | Farbenfabriken Bayer Ag | Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid |
DE2815578C2 (de) * | 1978-04-11 | 1986-01-16 | Bayer Ag, 5090 Leverkusen | Neue pharmazeutische Verwendung von Nimodipin |
DE3033919A1 (de) * | 1980-09-09 | 1982-04-22 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung |
DE3318649A1 (de) * | 1983-05-21 | 1984-11-22 | Bayer Ag, 5090 Leverkusen | Zweiphasenformulierung |
DE3424553A1 (de) * | 1984-07-04 | 1986-01-09 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung |
GB8729471D0 (en) * | 1987-12-17 | 1988-02-03 | Wyeth John & Brother Ltd | New crystal form |
-
1991
- 1991-09-11 DE DE4130173A patent/DE4130173A1/de not_active Withdrawn
-
1992
- 1992-08-31 DK DK92114835.9T patent/DK0531845T3/da active
- 1992-08-31 ES ES92114835T patent/ES2090432T3/es not_active Expired - Lifetime
- 1992-08-31 AT AT92114835T patent/ATE141052T1/de active
- 1992-08-31 DE DE59206868T patent/DE59206868D1/de not_active Expired - Lifetime
- 1992-08-31 EP EP92114835A patent/EP0531845B1/de not_active Expired - Lifetime
- 1992-09-04 MX MX9205077A patent/MX9205077A/es unknown
- 1992-09-08 CA CA002077704A patent/CA2077704C/en not_active Expired - Lifetime
- 1992-09-10 JP JP4266843A patent/JPH05229945A/ja active Pending
-
1995
- 1995-01-30 US US08/380,229 patent/US5599824A/en not_active Expired - Lifetime
-
1996
- 1996-09-05 GR GR960402317T patent/GR3020962T3/el unknown
-
1997
- 1997-04-03 HK HK41697A patent/HK41697A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE141052T1 (de) | 1996-08-15 |
EP0531845A1 (de) | 1993-03-17 |
GR3020962T3 (en) | 1996-12-31 |
CA2077704A1 (en) | 1993-03-12 |
ES2090432T3 (es) | 1996-10-16 |
HK41697A (en) | 1997-04-11 |
DE4130173A1 (de) | 1993-03-18 |
JPH05229945A (ja) | 1993-09-07 |
CA2077704C (en) | 2003-03-11 |
DK0531845T3 (da) | 1996-11-25 |
DE59206868D1 (de) | 1996-09-12 |
EP0531845B1 (de) | 1996-08-07 |
US5599824A (en) | 1997-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2967573D1 (en) | Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs | |
SE8701348L (sv) | Forbettringar av farmaceutiskt godtagabara salter | |
PT87703A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um derivado de 1,4-di-hidropiridina e um intensificador do fluxo transdermico | |
FR2694004B1 (fr) | Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent. | |
DK1275375T3 (da) | Fremgangsmåde til fremstilling af aerosolsammensætninger | |
HUT44499A (en) | Process for producing 2-thio-methyl-substituted-1,4-dihydropyridines and pharmaceutical compositions containing them | |
UA19285A (uk) | Спосіб одержаhhя таблеток hіфедіпіhу | |
IT8848259A0 (it) | 1,4-diidropiridine, loro procedimento di preparazione e loro applicazione come medicamenti | |
IL83413A0 (en) | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
IL75943A (en) | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
MX9205077A (es) | Preparado farmaceutico estable y procedimiento para su fabricacion. | |
IT8720260A0 (it) | Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti. | |
DK0536197T3 (da) | Ren, krystallinsk form af rifapentine | |
IT8448415A0 (it) | Derivati della 1,4-diidropiridina, loro preparazione e loro impiego come medicamenti | |
ZA86301B (en) | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
EP0184841A3 (en) | 1,4-dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing same | |
GR890100133A (el) | Μεθοδος παρασκευης παραγωγων 1,4 διυδροπυριδινης. | |
HUT60737A (en) | Process for producing new 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient | |
KR950702115A (ko) | 디히드로피리딘 유도체의 신규 의약 용도(novel medicinal use of dihydropyridine derivative) | |
FI942675A0 (fi) | Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi | |
HU9202873D0 (en) | 1,4-dihydropyridine derivatives of paf-antagonistic effect | |
SE9203824D0 (sv) | Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same | |
ATE126190T1 (de) | 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5- | |
SE8505801L (sv) | I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa | |
IL94502A0 (en) | Preparation of methyl,1,2-dihydroxypropan-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate |